Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Dawa Pharmaceutical Invest Sweden AB
AB
Active
Org 5568460041
C/O Kungspoprtsavenyn 4, 411 36
Göteborg
Other financial service activities, except insurance and pension funding n.e.c.
· NACE 6499
Est. 2011
0 employees
Watchlist
Share
Sweden
/
Companies
/
Other financial service activities, except insurance and pension funding n.e.c.
/
Dawa Pharmaceutical Invest Sweden AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
AG
Anders Gunnar Blohmé
Chief Auditor
Chief Auditor
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
BG
Bo Gunnar Rydlinger
Board of Directors
2022
EH
Eva Helene Rydlinger
Deputy Board Member
2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Sofama AB
Company
100%
100%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Dawa Pharmaceutical Invest Sweden AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
